No Data
No Data
Could tariffs in the USA lead to a shortage of Pharmaceuticals? The Industry warns that low-profit generic drugs are facing a production crisis.
The USA plans to impose additional tariffs on Pharmaceuticals, raising alarms in the generic drug Industry. Generic drugs account for 90% of the medication market in the USA, with thin profits and fierce competition; if tariffs are imposed, it could result in direct losses, leading some pharmaceutical companies to cease production and exit the market. Last year, the first quarter saw a record high in drug shortages in the USA, and the implementation of tariffs may exacerbate the supply crisis. India, as a major Global exporter of generic drugs, is likely to be hit hardest.
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
New tariffs coming? The Trump administration has launched an investigation into imported Pharmaceuticals and Semiconductors.
The Trump administration has initiated a National Security investigation into imported Pharmaceuticals and Semiconductors under Section 232 of the Trade Expansion Act, which may further escalate the comprehensive trade war initiated by Trump.
Trump has initiated a 232 investigation and plans to impose tariffs on Semiconductors and Pharmaceuticals.
The Trump administration officially launched investigations into the National Security of Semiconductors and Pharmaceuticals, paving the way for further tariff increases.
Healthcare Stocks Aren't a Shelter From the Tariff Storm -- Barrons.com
Express News | Trump stated that the USA will impose tariffs on pharmaceuticals.